Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications
This rapid review of 10 studies (n=180) found music to be a central component of psychedelic therapy, profoundly shaping emotional, imagery and embodied experiences—simultaneously anchoring and propelling participants—and that participant openness and participant-centred music selection associate with better immediate and longer-term outcomes. The authors recommend richer reporting on musical stimuli and greater involvement of music therapists to develop flexible, optimised music protocols for psychedelic-assisted treatment.
Abstract
Bonny Method of Guided Imagery and Music emerged following discontinuation of psychedelic therapy research in the early 1970s, but psychedelic therapy research has since revived. Music remains a vital component. This study examined participants’ experiences of music in psychedelic therapy research. A rapid review of qualitative and quantitative journal articles in four major databases was conducted in February to April, 2019, using the terms hallucinogens, psychedelic, “lysergic acid diethylamide,” psilocybin, ayahuasca, music, and/or “music therapy.” Of 406 articles retrieved, 10 were included (n = 180; 18–69 years old). Participants had varied backgrounds. Music was widely considered integral for meaningful emotional and imagery experiences and self-exploration during psychedelic therapy. Music transformed through its elicitation of anthropomorphic, transportive, synesthetic, and material sensations. Music could convey love, carry listeners to other realms, be something to “hold,” inspire, and elicit a deep sense of embodied transformation. Therapeutic influence was especially evident in music’s dichotomous elicitations: Music could simultaneously anchor and propel. Participant openness to music and provision of participant-centered music were associated with optimal immediate and longer-term outcomes. Many studies reported scarce details about the music used and incidental findings of music experienced. Further understanding of participants’ idiosyncratic and shared responses to music during drug therapy phases will inform optimal development of flexible music protocols which enhance psychedelic therapy. Music therapists could be involved in the psychedelic therapy research renaissance through assisting with research to optimize music-based protocols used. If psychedelics become approved medicines, music therapists may be involved in offering psychedelic therapy as part of therapeutic teams.
Research Summary of 'Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications'
Introduction
Psychedelic drugs such as LSD and psilocybin act primarily on serotonin 5HT2A/2C receptors and produce alterations in emotion, cognition, and perception. Research into their therapeutic use began in the mid-20th century and indicated potential benefits for conditions including anxiety, depression, addiction, and existential distress among patients with life‑threatening illness. Political and regulatory backlash from the 1970s greatly reduced clinical research until a resurgence from the 1990s onwards, with contemporary studies emphasising psilocybin because of its low toxicity and relatively short duration of action (typical sessions about 8 hours). Music has been a persistent component in psychedelic-assisted sessions since early work, with historical and contemporary researchers proposing that carefully chosen music can support emotional release, peak or mystical experiences, and continuity during altered states. O'Callaghan and colleagues carried out a rapid review to examine participants’ first‑hand experiences of music used in psychedelic therapy employing psilocybin, LSD, or ayahuasca. The stated aim was to synthesise participant-reported music experiences to inform playlist design and broader guidance for music provision in forthcoming psilocybin-assisted psychotherapy research, particularly in work addressing depression and anxiety associated with life‑threatening illness. The review therefore focuses specifically on participant self‑reports about music, rather than therapist perspectives or ethnographic descriptions of nonclinical use.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Pro members can view the original manuscript directly in the browser.
Study Details
- Study Typemeta
- Journal
- Compounds
- Topics
- Author
- APA Citation
O’Callaghan, C., Hubik, D. J., Dwyer, J., Williams, M., & Ross, M. (2020). Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications. Journal of Music Therapy, 57(3), 282-314. https://doi.org/10.1093/jmt/thaa006
References (28)
Papers cited by this study that are also in Blossom
Barrett, F. S., Preller, K. H., Kaelen, M. · International Review of Psychiatry (2018)
Slevc, L. R., Barrett, F. S., Robbins, H. et al. · Frontiers in Psychology (2017)
Belouin, S. J., Henningfield, J. E. · Neuropharmacology (2018)
Belser, A. B., Agin-Liebes, G. I., Swift, T. C. et al. · Journal of Humanistic Psychology (2017)
Bonson, K. R. · Psychopharmacology (2017)
Carbonaro, T. M., Hurwitz, E., Johnson, M. W. · Psychopharmacology (2017)
Carhart-Harris, R. L., Bolstridge, M., Rucker, J. et al. · Lancet Psychiatry (2016)
Garcia-Romeu, A., Griffiths, R. R., Johnson, M. W. · Current Drug Abuse Reviews (2015)
Kirchner, K. · Journal of Psychopharmacology (2014)
Griffiths, R. R., Johnson, M. W. · Journal of Psychopharmacology (2016)
Show all 28 referencesShow fewer
Griffiths, R. R., Johnson, M. W., Richards, W. A. et al. · Psychopharmacology (2011)
Griffiths, R. R. · Journal of Psychopharmacology (2008)
Griffiths, R. R., Richards, W. A., Mccann, U. et al. · Journal of Psychopharmacology (2006)
Grob, C. S., Danforth, A. L., Chopra, G. S. et al. · JAMA Psychiatry (2011)
Johnson, M. W., Garcia-Romeu, A., Griffiths, R. R. · The American Journal of Drug and Alcohol Abuse (2016)
Johnson, M. W., Garcia-Romeu, A., Johnson, P. S. et al. · Journal of Psychopharmacology (2017)
Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)
Kaelen, M., Barrett, F. S., Roseman, L. et al. · Psychopharmacology (2015)
Kaelen, M., Giribaldi, B., Raine, J. et al. · Psychopharmacology (2018)
Loizaga-Velder, A., Verres, R. · Journal of Psychoactive Drugs (2014)
Moreno, F. A., Wiegand, C. B., Taitano, E. K. et al. · Journal of Clinical Psychiatry (2006)
Nichols, D. E. · Pharmacological Reviews (2016)
Noorani, T., Garcia-Romeu, A., Swift, T. C. et al. · Journal of Psychopharmacology (2018)
Ross, S., Bossis, A. P., Guss, J. et al. · Journal of Psychopharmacology (2016)
Swift, T. C., Belser, A. B., Agin-Liebes, G. et al. · Journal of Humanistic Psychology (2017)
Talin, P., Sanabria, E. · International Journal of Drug Policy (2017)
Nutt, D. J., Carhart-Harris, R. L. · Current Drug Abuse Reviews (2015)
Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)
Cited By (7)
Papers in Blossom that reference this study
Stellmacher, J., Schmidt, C., Aicher, H. D. et al. · Frontiers in Psychiatry (2026)
Beaussant, Y., Tarbi, E., Nigam, K. B. et al. · General Hospital Psychiatry (2025)
Barta, S., Brooker, J., O’Callaghan, C. · Journal of Palliative Medicine (2025)
Weiss, B., Leor Roseman, •., Giribaldi, B. et al. · International Journal of Mental Health and Addiction (2024)
Allen, J., Dames, S., Foldi, C. J. et al. · Molecular Psychiatry (2024)
Cruz, L., Tófoli, L.F., Araújo, D. B. et al. · Scientific Reports (2023)
Adamska, I., Finc, K. · Psychopharmacology (2023)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.